Publications by authors named "G J Viscomi"

Article Synopsis
  • This study explores using waste silt from limestone production as a filler in geopolymer cement.
  • The first phase investigates calcination conditions, identifying that 750 °C for 2 hours optimizes compressive strength for cement made with sodium or potassium alkali solutions.
  • In the second phase, results indicate that incorporating about 55% silt improves strength while meeting European leaching standards for trace elements.
View Article and Find Full Text PDF

Every year, up to 3 billion tons of non-renewable natural aggregates are demanded by the construction sector and approximately 623 million tons of waste (mining and quarrying) was produced in 2018. Global efforts have been made to reduce the number of virgin aggregates used for construction and infrastructure sectors. According to the revised waste framework directive in Europe, recycling at least 70% of construction and demolition waste materials by 2020 was obligatory for all member states.

View Article and Find Full Text PDF

Carbon footprint reduction of paving materials could be explored through recycling mining by-products into different applications, which will preserve natural resources and decrease environmental issues. One possible approach is to reuse quarry dust and mining ore waste as precursors in geopolymer applications. geopolymers are mineral polymers rich in aluminosilicates with an amorphous to a semi-crystalline three-dimensional structure.

View Article and Find Full Text PDF

Kambo is a substance obtained from the skin secretions of a frog, Phyllomedusa bicolor, popular in the Amazon region, which is administered via the transdermal route. We report a case of 42-year-old man found dead in his house. Near the corpse, a plastic box labeled as "Kambo sticks" was found.

View Article and Find Full Text PDF

Background: Rifaximin is an antibiotic, acting locally in the gastrointestinal tract, which may exist in different crystal as well as amorphous forms. The current marketed rifaximin formulation contains polymorph alpha, the systemic bioavailability of which is very limited. This study compared the pharmacokinetics of this formulation with those of the amorphous form.

View Article and Find Full Text PDF